• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The German Network for Personalized Medicine to enhance patient care and translational research.

作者信息

Illert A L, Stenzinger A, Bitzer M, Horak P, Gaidzik V I, Möller Y, Beha J, Öner Ö, Schmitt F, Laßmann S, Ossowski S, Schaaf C P, Hallek M, Brümmendorf T H, Albers P, Fehm T, Brossart P, Glimm H, Schadendorf D, Bleckmann A, Brandts C H, Esposito I, Mack E, Peters C, Bokemeyer C, Fröhling S, Kindler T, Algül H, Heinemann V, Döhner H, Bargou R, Ellenrieder V, Hillemanns P, Lordick F, Hochhaus A, Beckmann M W, Pukrop T, Trepel M, Sundmacher L, Wesselmann S, Nettekoven G, Kohlhuber F, Heinze O, Budczies J, Werner M, Nikolaou K, Beer A J, Tabatabai G, Weichert W, Keilholz U, Boerries M, Kohlbacher O, Duyster J, Thimme R, Seufferlein T, Schirmacher P, Malek N P

机构信息

Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Department of Medicine III, Faculty of Medicine, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.

出版信息

Nat Med. 2023 Jun;29(6):1298-1301. doi: 10.1038/s41591-023-02354-z.

DOI:10.1038/s41591-023-02354-z
PMID:37280276
Abstract
摘要

相似文献

1
The German Network for Personalized Medicine to enhance patient care and translational research.德国个性化医疗网络旨在加强患者护理和转化研究。
Nat Med. 2023 Jun;29(6):1298-1301. doi: 10.1038/s41591-023-02354-z.
2
Future of Team-based Basic and Translational Science in Radiation Oncology.团队式基础与转化放射肿瘤学的未来。
Semin Radiat Oncol. 2024 Oct;34(4):370-378. doi: 10.1016/j.semradonc.2024.07.007.
3
Progress and perspective of organoid technology in cancer-related translational medicine.类器官技术在癌症相关转化医学中的进展与展望
Biomed Pharmacother. 2022 May;149:112869. doi: 10.1016/j.biopha.2022.112869. Epub 2022 Mar 28.
4
Advances in Molecular and Translational Medicine.分子与转化医学进展。
Int J Mol Sci. 2023 Apr 23;24(9):7726. doi: 10.3390/ijms24097726.
5
Endothelial Biomarkers and Translational Medicine: Still a Challenge.内皮生物标志物与转化医学：仍然是一项挑战。
Arq Bras Cardiol. 2022 Oct;119(4):551-552. doi: 10.36660/abc.20220533.
6
The journey from bench to bedside-it takes a science village.从实验室到临床应用的旅程——这需要一个科研群体。
Biochem Cell Biol. 2024 Aug 1;102(4):299-304. doi: 10.1139/bcb-2024-0075. Epub 2024 Apr 19.
7
Translational Medicine and Implementation Science: How to Transform What We Know Into What We Do.转化医学与实施科学：如何将我们所知转化为我们所行。
Arq Bras Cardiol. 2022 Aug;119(2):342-345. doi: 10.36660/abc.20211029.
8
Precision Medicine, AI, and the Future of Personalized Health Care.精准医学、人工智能与个性化医疗的未来
Clin Transl Sci. 2021 Jan;14(1):86-93. doi: 10.1111/cts.12884. Epub 2020 Oct 12.
9
Integrated ACMG-approved genes and ICD codes for the translational research and precision medicine.整合 ACMG 批准的基因和 ICD 编码，用于转化研究和精准医学。
Database (Oxford). 2023 May 17;2023. doi: 10.1093/database/baad033.
10
The Translational Science Spectrum.转化科学光谱。
J Obstet Gynecol Neonatal Nurs. 2021 Nov;50(6):655-658. doi: 10.1016/j.jogn.2021.09.007. Epub 2021 Oct 11.

引用本文的文献

1
Assessing the catchment area of German comprehensive cancer centers by merging geographic healthcare data - an initiative of the ONCOnnect consortium.通过合并地理医疗数据评估德国综合癌症中心的服务区域——ONCOnnect联盟的一项倡议。
J Cancer Res Clin Oncol. 2025 Sep 10;151(9):250. doi: 10.1007/s00432-025-06272-0.
2
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.CG>TG突变频率作为卵巢癌和乳腺癌同源重组缺陷的阴性预测指标。
Commun Biol. 2025 Jul 29;8(1):1126. doi: 10.1038/s42003-025-08529-3.
3
Large language models-enabled digital twins for precision medicine in rare gynecological tumors.

本文引用的文献

1
Implementing precision medicine in a regionally organized healthcare system in Sweden.在瑞典的区域组织化医疗保健系统中实施精准医疗。
Nat Med. 2022 Oct;28(10):1980-1982. doi: 10.1038/s41591-022-01963-4.
2
A national precision cancer medicine implementation initiative for Norway.挪威的一项全国性精准癌症医学实施计划。
Nat Med. 2022 May;28(5):885-887. doi: 10.1038/s41591-022-01777-4.
3
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.通过标志性细胞因子中心重塑免疫介导的炎症性疾病
用于罕见妇科肿瘤精准医疗的基于大语言模型的数字孪生体
NPJ Digit Med. 2025 Jul 9;8(1):420. doi: 10.1038/s41746-025-01810-z.
4
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer Treatment.致敬乌尔里克·林伯格：基于多组学的精准癌症治疗患者分层
Biomolecules. 2025 May 10;15(5):693. doi: 10.3390/biom15050693.
5
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps.关于临床疗效和评估差距的分子肿瘤学专家组数据的系统评价和荟萃分析。
NPJ Precis Oncol. 2025 Apr 2;9(1):96. doi: 10.1038/s41698-025-00865-1.
6
Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards.助力个性化肿瘤学：分子肿瘤委员会数字支持与可视化工具的发展
BMC Med Inform Decis Mak. 2025 Jan 16;25(1):29. doi: 10.1186/s12911-024-02821-8.
7
Construction and optimization of health behavior prediction model for the older adult in smart older adult care.智慧老年照护中老年人健康行为预测模型的构建与优化
Front Public Health. 2024 Dec 18;12:1486930. doi: 10.3389/fpubh.2024.1486930. eCollection 2024.
8
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123).曲美替尼联合羟氯喹或哌柏西利治疗晚期转移性胰腺癌：来自回顾性、多中心队列研究（AIO AIO-TF/PAK-0123）的数据。
J Cancer Res Clin Oncol. 2024 Oct 1;150(10):438. doi: 10.1007/s00432-024-05954-5.
9
Advancements in Nanoporous Materials for Biomedical Imaging and Diagnostics.用于生物医学成像与诊断的纳米多孔材料的进展
J Funct Biomater. 2024 Aug 14;15(8):226. doi: 10.3390/jfb15080226.
10
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.原发性中枢神经系统肿瘤患者的综合基因分析及分子靶向治疗
NPJ Precis Oncol. 2024 Aug 14;8(1):180. doi: 10.1038/s41698-024-00674-y.
N Engl J Med. 2021 Aug 12;385(7):628-639. doi: 10.1056/NEJMra1909094.
4
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.综合基因组学和转录组学分析指导罕见癌症患者的治疗决策。
Cancer Discov. 2021 Nov;11(11):2780-2795. doi: 10.1158/2159-8290.CD-21-0126. Epub 2021 Jun 10.
5
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany.欧洲开拓性的精准医学：瑞典基因组医学和德国个体化医疗中心（ZPM）的联合观点。
Semin Cancer Biol. 2022 Sep;84:242-254. doi: 10.1016/j.semcancer.2021.05.026. Epub 2021 May 24.
6
How personalised medicine will transform healthcare by 2030: the ICPerMed vision.到 2030 年，个性化医疗将如何改变医疗保健：ICPerMed 的愿景。
J Transl Med. 2020 Apr 28;18(1):180. doi: 10.1186/s12967-020-02316-w.
7
German Cancer Consortium (DKTK) - A national consortium for translational cancer research.德国癌症研究联合会（DKTK）- 一个国家癌症转化研究联合会。
Mol Oncol. 2019 Mar;13(3):535-542. doi: 10.1002/1878-0261.12430. Epub 2019 Jan 9.
8
Off-label drug use in oncology: a systematic review of literature.肿瘤学中的药物非标签使用：文献系统综述
J Clin Pharm Ther. 2017 Jun;42(3):251-258. doi: 10.1111/jcpt.12507. Epub 2017 Feb 5.